Join the global community of corporate and public-sector finance industry leaders reading Global Finance monthly in print.

Click Here

Economics, Policy & Regulation

Where To Draw The Line On Big Data Privacy?

Cover Story | Supplement As data sharing becomes more common, individual privacy seems to be more luxury than norm. But corporations working with big-data analytics must pay attention to how many personal details they gather about their customers, lest they cross the invisible line of what is acceptable and what is not—and anger their client base.

Capital Raising & Corporate Finance

Will Japanese Companies Bow To Shareholders?

Management | Corporate Governance Japanese corporate culture, long considered one of the least shareholder-friendly among developed nations, may be softening up, with a little nudge from prime minister Shinzo Abe.

Capital Raising & Corporate Finance

CEO Pay Disclosure Shadows Public Companies

SEC & Executive Compensation | Five years after the 2010 Dodd-Frank financial reform act, several of its controversial corporate governance provisions on executive compensation continue to wend their way through the system.

Country Report

Egyptian Economy Turns As Reforms Take Hold

Country Report | Egypt Egypt may be on the verge of a major turnaround, as the most populous country in the Arab world looks set for sustained growth, lower unemployment and a manufacturing renaissance under president Abdel Fattah al-Sisi.

Capital Raising & Corporate Finance

Ford’s Swaps Vehicle Passes CFTC Inspection

Capital Markets | Derivatives Life may have just become a bit easier for finance executives at companies with captive finance units—which is to say, almost all automakers and scores of equipment manufacturers.

Economics, Policy & Regulation

India | Is The Bloom Off The Rose For Narendra Modi?

India | Indian prime minister Narendra Modi celebrated his one-year anniversary in office in May, but the jury is still out on whether he’ll justify the hope that has been invested his new government.

Capital Raising & Corporate Finance

Israel’s Teva Bids $40 Billion For US Generic-Drug Rival

Capital Markets | M&A Pharmaceuticals In what could become Israel’s biggest cross-border M&A deal ever, Teva Pharmaceutical Industries made an unsolicited $40 billion offer to acquire Mylan, a Pennsylvania-based drugmaker registered in the Netherlands with operational headquarters in the UK.

Economics, Policy & Regulation

Nicola Sturgeon, A Scottish Thorn In David Cameron’s Side

United Kingdom | Many questions are still being asked about David Cameron’s dramatic win on May 7. How did opinion polls, which predicted a tight race between Conservatives and Labour and even a Labour win, get it so wrong?
arrow-chevron-right-redarrow-chevron-rightbutton-arrow-left-greybutton-arrow-left-red-400button-arrow-left-red-500button-arrow-left-red-600button-arrow-left-whitebutton-arrow-right-greybutton-arrow-right-red-400button-arrow-right-red-500button-arrow-right-red-600button-arrow-right-whitecaret-downcaret-rightclosecloseemailfacebook-square-holdfacebookhamburger-newhamburgerinstagramlinkedin-square-1linkedinpauseplaysearch-outlinesearchsubscribe-digitalsubscribe-printtwitter-square-holdtwitteryoutube